25 Leading Digital Health Investors in the Healthcare Industry

Digital Health Investors are driving the next wave of healthcare innovation by funding startups focused on artificial intelligence, virtual care, digital therapeutics, remote patient monitoring, and consumer health technologies. As venture capital continues to accelerate digital transformation across healthcare, understanding which investors are actively backing emerging companies has become essential for founders, healthcare marketers, and industry leaders seeking new opportunities. 

For businesses expanding their outreach, a Physicians Email List helps connect with decision-makers, healthcare providers, and innovators across the industry. This guide highlights 25 leading digital health investors, explores their investment focus, and provides practical insights to help startups identify the right funding partners and navigate today’s competitive healthcare investment landscape.

Why Digital Health Investment Matters

Digital health funding has grown from a niche category a decade ago into a mainstream part of the venture landscape. U.S. digital health startups raised roughly $14.2 billion in 2025, a 35% increase over the prior year, and funding has continued at a strong pace into 2026, with AI-enabled companies capturing more than half of all dollars invested. Clinical workflow tools, insurance and benefits navigation platforms, value-based care infrastructure, and mental health technology have all drawn significant capital, alongside a wave of interest in ambient AI documentation tools that reduce the time clinicians spend on charting.

This growth means more capital is available for founders, but it also means more competition for investor attention. Understanding the specific focus areas, check sizes, and portfolio history of the investors most active in the space can help founders target their outreach more effectively — and help anyone else tracking the sector understand where the money, and the influence, is concentrated.

What to Look for in a Digital Health Investor

Before diving into the list, it helps to understand what separates a strong digital health investor from a generalist fund dabbling in the space:

• Domain expertise — Investors with clinical or health system backgrounds can offer credibility and introductions that generalist VCs typically can’t.
• Stage focus — Some investors specialize in pre-seed and seed rounds, others focus exclusively on growth-stage and pre-IPO deals.
• Check size and lead vs. follow behavior — Knowing whether a firm typically leads rounds or writes smaller follow-on checks helps founders plan a realistic capital stack.
• Portfolio thesis — Firms increasingly specialize in sub-categories like women’s health, behavioral health, value-based care, or health AI infrastructure.
• Track record with exits — A firm’s history with IPOs, acquisitions, and follow-on rounds signals how well it can support a company through multiple stages of growth.

With those criteria in mind, here is a closer look at 25 investors that are actively shaping the digital health funding landscape.

The 25 Leading Digital Health Investors

1. Rock Health

Rock Health was the first dedicated digital health venture fund and remains one of the most recognized names in the space. It typically writes early checks, from pre-seed through Series A, and has backed category-defining companies including Omada Health and Collective Health. Its widely cited annual funding reports have also become a standard industry reference point for tracking digital health investment trends.

2. Oak HC/FT

Oak HC/FT is among the largest dedicated healthcare-and-fintech specialist funds, investing from early to growth stage. Co-founded by Annie Lamont, the firm has backed Devoted Health, Maven, Noom, and CareBridge, and has been a lead investor in high-profile health AI rounds, including Ambience Healthcare’s Series C. Oak is known for staying closely involved with portfolio companies well beyond the initial check.

3. General Catalyst

General Catalyst has built one of the most active healthcare investment practices among multi-stage generalist firms, with a portfolio spanning clinical AI, care delivery, and health system infrastructure. The firm has increasingly positioned itself as a long-term partner to health systems themselves, not just to startups, blurring the line between venture investor and strategic operator.

4. Andreessen Horowitz (a16z Bio + Health)

Andreessen Horowitz runs one of the largest dedicated bio and health practices in venture capital, with billions of dollars committed across multiple funds. The team, which includes healthcare services lead Julie Yoo and physician-scientist Vineeta Agarwala, invests across digital therapeutics, health AI, and computational biology, and has backed companies like Hippocratic AI.

5. GV (Google Ventures)

GV, Google’s venture capital arm, has a substantial healthcare and technology portfolio and has been an active backer of AI-native clinical tools. The firm led rounds in OpenEvidence, a clinical decision-support platform that has grown rapidly in usage among practicing physicians, reflecting GV’s interest in AI-powered tools built specifically around clinical workflows.

6. Bessemer Venture Partners

Bessemer Venture Partners invests across stages in healthcare, SaaS, and enterprise software, and has a long history of early bets on digital health companies. The firm was an early backer of Abridge and supported Hinge Health through its public listing, giving it a track record that spans both AI-driven clinical tools and value-based musculoskeletal care.

7. New Enterprise Associates (NEA)

NEA is one of the most active multi-stage healthcare investors by deal volume, with thousands of investments spanning digital health, biotech, and medtech. The firm has been a long-term backer of Tempus AI, a precision oncology and AI platform that completed a high-profile public offering, underscoring NEA’s ability to support portfolio companies from early rounds through IPO.

8. Khosla Ventures

Khosla Ventures takes a notably contrarian, technology-first approach to healthcare investing, backing companies like Curai Health along with stakes in Abridge and Sword Health. The firm is known for tolerating higher technical risk in pursuit of category-defining outcomes, making it a common name among AI-native health startups.

9. Sequoia Capital

Sequoia has increasingly turned its attention to health AI, leading OpenEvidence’s first institutional round and backing Freed, an AI scribe built for independent and small medical practices. As a multi-stage generalist firm with enormous follow-on capacity, Sequoia’s involvement often signals strong conviction that a healthcare startup can scale well beyond its original niche.

10. Lightspeed Venture Partners

Lightspeed closed more than $9 billion across six funds in late 2025 and has used part of that capital to lead major digital health rounds, including Neko Health’s Series B for AI-powered preventive full-body scanning. The firm also backs Abridge, reinforcing its position among the most active generalist investors in health AI.

11. Founders Fund

Founders Fund has backed Freenome, a multi-cancer early-detection test that has pursued a public listing, along with other ambitious, technically difficult healthcare bets. The firm’s approach tends to favor founders solving hard scientific or engineering problems rather than incremental improvements to existing care models.

12. Venrock

Venrock has a long history of supporting early-stage startups at the intersection of healthcare, biotech, and healthcare IT. The firm’s healthcare practice spans patient care technology and digital health infrastructure, and it has remained a consistent presence in early rounds for companies building at the technical edge of clinical innovation.

13. 7wireVentures

7wireVentures focuses specifically on early-stage digital health companies that empower consumers to take a more active role in their own care. Based in Chicago, the firm has backed Transcarent, a healthcare navigation platform that reached unicorn status, along with dozens of other portfolio companies focused on connected, consumer-driven health.

14. Define Ventures

Define Ventures positions itself as one of the largest early-stage digital health funds with deep operational expertise, investing from seed through Series B. The firm led Layer Health’s Series A and has built a portfolio focused on digital health transformation across clinical and administrative workflows.

15. F-Prime Capital

F-Prime Capital, Fidelity’s venture arm, focuses on healthcare IT and digital therapeutics from early to growth stage. As part of a large, well-capitalized institutional platform, F-Prime is often noted for its patience with longer healthcare development timelines compared to more traditional consumer-tech-focused funds.

16. Lux Capital

Lux Capital is known for backing deep-tech and frontier science companies, and its healthcare portfolio includes Benchling, Alife, Everly Health, and Workit Health. The firm brings a strong scientific and engineering lens to its healthcare investments, often gravitating toward companies solving fundamentally hard technical problems.

17. Kleiner Perkins

Kleiner Perkins invests in technology and health sectors at the early stage, with a long track record across consumer and enterprise health technology. The firm has been part of major recent healthcare rounds, including OpenEvidence, reflecting its continued interest in AI tools built for clinical use.

18. Canaan

Canaan is an early-stage venture capital firm with a healthcare portfolio focused on improving access to care and patient outcomes through digital health innovation. The firm typically backs founders early, before a company has fully proven its business model, making it a common first institutional check for healthcare startups.

19. Mayfield Fund

Mayfield Fund partners with early-stage startups building breakthrough technologies across healthcare and other sectors. Its healthcare investments often emphasize technical differentiation, and the firm has a long history of supporting founders through multiple funding rounds as their companies mature.

20. .406 Ventures

.406 Ventures is a Boston-based investor with a digital health and health IT focus, typically investing at the Series A and B stage. The firm has built a reputation for backing East Coast healthtech companies working on data platforms and healthcare IT infrastructure, often alongside other regional specialist investors.

21. Flare Capital Partners

Flare Capital Partners is a healthcare-focused venture firm known for its close ties to health system and payer strategic investors, which gives portfolio companies unusual access to enterprise customers early on. The firm has backed HealthVerity and other data and infrastructure companies central to the digital health ecosystem.

22. LRVHealth

LRVHealth is a specialist healthcare investor with deep relationships across health systems, payers, and pharmacy benefit managers, giving its portfolio companies direct access to potential enterprise customers. The firm typically invests at early and growth stages in companies building infrastructure for value-based care and care delivery transformation.

23. Town Hall Ventures

Town Hall Ventures focuses on healthcare investments serving underserved and complex patient populations, including Medicaid and dual-eligible populations. The firm has backed Cityblock Health, a value-based care company built specifically around community health needs, reflecting its focus on equity-driven healthcare innovation.

24. Foresite Capital

Foresite Capital is a growth-stage investor with a strong track record in healthcare and life sciences, and has backed Thyme Care, a value-based cancer care company. The firm typically writes larger checks at later stages, supporting companies as they scale from early product-market fit toward broader commercial deployment.

25. Maverick Ventures

Maverick Ventures, spun out of Maverick Capital, invests across early and growth stages in healthcare AI and tech-enabled services. With a solid network of healthcare operators supporting its portfolio, the company is renowned for its patient, long-horizon approach and has supported Cityblock Health, Devoted Health, and Hims & Hers.

Investor Snapshot 

How Founders Can Approach These Investors

Reaching out to a digital health investor is rarely as simple as sending a cold pitch deck. A few practical steps improve the odds of a meaningful response:

• Get warm introductions where possible. Healthcare-specific investors receive a high volume of inbound interest, and a referral from a portfolio founder, health system contact, or clinical advisor often carries more weight than a cold email.
• Lead with clinical or regulatory clarity. Investors in this space expect a clear answer on regulatory pathway, reimbursement strategy, and clinical validation, not just a compelling product story.
• Match the stage to the fund. Pitching a growth-stage firm like Foresite Capital with a pre-seed idea, or a seed specialist like Rock Health with a late-stage round, wastes time on both sides.
• Show real usage data. Investors increasingly expect evidence of engagement, retention, or clinical outcomes rather than projections alone, particularly at Series A and beyond.
• Understand the firm’s network value. Some investors, like Flare Capital Partners and LRVHealth, offer direct access to health system and payer customers, which can matter as much as the check itself for an early-stage company.

Conclusion

The digital health investment landscape has matured into a deep, well-capitalized ecosystem spanning specialist healthcare funds, multi-stage generalist firms, and corporate venture arms, each bringing a different mix of capital, network, and domain expertise to the table. From early-stage specialists like Rock Health and Canaan to growth-stage investors like Foresite Capital, the 25 firms profiled here represent a broad cross-section of where digital health capital and influence are concentrated today. 

Just as a well-maintained Physician Mailing List helps healthcare marketers reach the right clinical decision-makers with precision, understanding which investors are active — and where their specific interests lie — helps founders and industry watchers direct their attention where it is most likely to pay off. Matching a company’s stage, clinical focus, and growth strategy to the right investor remains the clearest path to building a productive, long-term funding relationship.